this post links back to last Friday's tape of trades ..

New Post Public Reply Private Reply Replies (1) Message Board
4kids 4kids #55829
519
this post links back to last Friday's tape of trades ..

in a nutshell .. here's that historical data (5.3.19)


Detailed Quote:IPIX @ ask NC
INNOVATION PHARMACEUTICALS INC
0.171Up 0.015 (9.62 %) AS OF 3:54:23PM ET 05/03/2019


Change 0.015
% Change 9.62%


Bid 0.16
Bid Size 5000

Ask 0.171
Ask Size 6702


Open 0.156
Day High 0.19 .. .034c *liquidity*
Day Low 0.156
Previous Close
05/02/2019 0.156

52-Week High
05/16/2018 0.69475

52-Week Low
12/31/2018 0.07


Price Performance (Last 52 Weeks)
05/02/2019 -62.95%


Volume 403,294
Volume (10 day Average) 366,852
Volume (90 day Average) 419,712


while we await EOD *volume* .. here's today's info as of this post

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2105Down -0.0815 (-27.91 %)AS OF 11:56:19AM ET 05/10/2019

Last Trade 0.2105
Trade Time 11:56:19am ET

Change -0.0815
% Change -27.91%

Bid 0.2115
Bid Size 2500

Ask 0.219
Ask Size 2500


Open 0.287
Day High 0.32
Day Low 0.2039

Previous Close
05/09/2019 0.292

52-Week High
05/16/2018 0.69475

52-Week Low
12/31/2018 0.07

Price Performance (Last 52 Weeks)
05/09/2019 -19.34%


Volume 1,745,466
Volume (10 day Average) 831,474
Volume (90 day Average) 467,984


between last Friday and today .. IPIX has seen *volume* and lots of it


*imo* NR having learned something in mid to late Feb 2019 and coming to
the *brick wall* of IPIX's 52 week high being *reset lower* effective 5.16.18/19
pulled a classic *set up* (helium out of the ole' balloon) and ran IPIX (which was
another imo *risky gamble* as was NRs' effort beginning last September 12th of volume injection that doesn't align)

i say risky because of *volume* and PPS increase on *air* potentially means loss of control (which was visible a few x earlier this week .. Monday)

how to combat that risk NR faces ..


get the volume (pull GTCs up to a specific price point) b4 executing the turn

import new decoys .. we had at least 2 (CFGN/ASCM) to join priors ..

delay RT l2 data via OTC markets ..

have a notorious *player* post *info* via the vehicle of choice (sucker punch newbies)

keep infesting SMBs with new multi/s

NR is desperately trying to condition *retail* ..


as i've noted .. investors invest .. traders trade .. NR manipulates

NRs' set up is part of NRs' *pattern* .. the flat out easiest aspect NR controls on the OTC is the PPS

NR via *efforts* will always CONflate the I/O vs the FLOAT .. it is the Float that is freely traded .. to get the float info .. one takes the I/O less restricted for freely trading shares

that is why NRs' *effort* of pumping 55M~ in volume in the last 4 months of 2018
never passed the smell test beyond their obvious .. of demoralizing investors to such a degree by brutally (yet again) compressing IPIX's PPS from a high of 5805c on 9.7.18 to a low of 7c on 12.31.18

this last week revealed just how desperate NR is ..

imo nothing beats an aware mgmt and an educated investor

4kids











1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Lawsuit Hits Desert Resort Management

Updated Category News Views 0

Desert Resort Management in Labor Hot Seat Alright, here's a twist that might make your coffee spill—Desert Resort Management, Inc. is caught in a legal whirlwind in Riverside County. The heavy hitters at Blumenthal Nordrehaug Bhowmik De Blouw LLP have slapped a lawsuit right in their face, alleging some grimy labor practices. They're claiming that the company wasn't...

Continue Reading
Celina Graves Joins Expanding GoLive Streamers Platform

Updated Category News Views 0

Celina Graves Breaks New Ground on GoLive Streamers You'd think television capture all the talent buzz, but nope. Celina Graves, known from her semifinalist run on America's Got Talent, is diving into new waters by joining GoLive Streamers. She's stirring up the scene by making her performances more personal, stretching beyond the flatness of your typical TV appearance....

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 5

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
J.P. Morgan, Thunes Partner for Global Payment Integration

Updated Category News Views 0

You don't need a crystal ball to see J.P. Morgan's playing the long game by teaming up with Thunes. In this world, where cash is digital and the reach is global, it's all about speed and scale—brushing elbows with the right partners makes all the difference. Sometimes it's about knowing when to hitch your wagon to a reliable workhorse, especially when global commerce is...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Craig Hospital Expands: A Milestone for Rehab Care

Updated Category News Views 0

A Bold Step Forward in Neurorehabilitation Over a September sky in Englewood, Colorado, a ceremonial beam rose, marking a major milestone for Craig Hospital. It's not just steel and concrete; it's hope and progress for many who've found themselves at the mercy of neurological injuries. Celebrating the 'topping out' of their expanded campus, Craig's latest step forward...

Continue Reading
Elevest's Fund 70: High Hopes in Dallas Tower Deal

Updated Category News Views 0

Aiming High in the Heart of Dallas Rolling the dice in downtown Dallas isn't for the faint-hearted, but Elevest Capital is strutting in with swagger. Their 70th fund acquisition—a 229-unit high-rise—is rocking the highest going-in cap rate the firm has ever snagged at 6.4%. Built in 2007 and lounging at a comfy 93% occupancy with zero concessions, this property sure...

Continue Reading
AHN Healthcare@Home Celebrates Fourth Top Workplace Win

Updated Category News Views 0

Four-Time Top Workplace Champ You want to talk consistency? Let's talk about AHN Healthcare@Home pulling in that Pittsburgh Top Workplace award four years running. It's no small feat, especially in the healthcare sector where employee burnout isn't just a buzzword—it's a daily challenge. How did a home health and hospice outfit like AHN land this honor? Well, it's all...

Continue Reading
NUS Unveils eLuminator: A Leap for Robotics & Healthcare

Updated Category News Views 0

Game-Changing Electronic Skin From NUS It's not every day you come across tech that could shake up multiple industries, but that's just what the National University of Singapore has cooked up with their latest brainchild—the eLuminator. This ain't your everyday wearable tech. We're talking a skin-like device that can both detect and show touch in real-time, no fiddly...

Continue Reading
RiskScout Rides High on Funding, Tackles Financial Crime

Updated Category News Views 0

A Fresh Injection to Combat Financial Crime Capital's flowing into RiskScout's coffers thanks to a new funding round, and it's not just about cash—it’s about gearing up for a battle against financial crime. The round was led by LiveOak Ventures, who aren't new to the block, alongside other players like Castle Creek Launchpad and Alloy Labs. After tripling their...

Continue Reading

Top 5 Most Recently Viewed Articles

Draganfly Launches New Offering of Common Shares and Warrants

Updated Category News Views 203

Overview of Draganfly's Public Offering Draganfly Inc. (NASDAQ: DPRO), a leading name in drone technology based in Saskatoon, has recently announced an exciting opportunity for investors. The company is poised to commence an underwritten public offering in the United States, consisting of units comprised of common shares, or pre-funded warrants, along with warrants to...

Continue Reading
Class Action Lawsuit Overview for DMC Global Investors

Updated Category News Views 137

Class Action Lawsuit Against DMC Global Inc. Pomerantz LLP has filed a class action lawsuit concerning DMC Global Inc. (“DMC” or the “Company”) (NASDAQ: BOOM). This action is particularly relevant to investors who believe they have incurred losses related to their investment in DMC. If you think you may have been affected or wish to know more, it is crucial to act...

Continue Reading
Investing Insights: Broadcom's Position Among Peers in Semiconductors

Updated Category News Views 119

Understanding Broadcom's Standing in the Semiconductor Sphere In today's fast-paced semiconductor landscape, it is essential for investors and analysts to conduct in-depth evaluations of companies. This article delves into Broadcom (NASDAQ: AVGO) and compares its performance with notable competitors within the Semiconductors & Semiconductor Equipment industry. By...

Continue Reading
Exploring the Application Transformation Market's Future Growth

Updated Category News Views 121

Application Transformation Market Size and Growth Potential As industries globally continue to advance digitally, the Application Transformation Market is experiencing remarkable growth. Currently valued at approximately USD 11.56 billion, this sector is projected to expand significantly, reaching an estimated USD 42.40 billion in the years to come. This transformation is...

Continue Reading
Emergent BioSolutions Secures $400M in Vaccine Orders for 2024-2025

Updated Category News Views 191

Emergent BioSolutions Seals Major Vaccine Orders In a noteworthy announcement, Emergent BioSolutions Inc. has confirmed that it has secured around $400 million in orders for the years 2024 and 2025, primarily centered on its vaccinia, smallpox, and mpox vaccine product portfolio. This latest development underscores the company's essential role in bolstering public health...

Continue Reading